Psychosocial Interventions for Pain Management in Breast Cancer Survivors: A RE-AIM Evaluation

J Clin Psychol Med Settings. 2023 Mar;30(1):182-196. doi: 10.1007/s10880-022-09874-9. Epub 2022 May 13.

Abstract

Psychosocial interventions for breast-cancer-related pain are effective, yet over 45% of survivors continue to struggle with this often-chronic side effect. This study evaluated multilevel indicators that can influence successful translation of interventions into clinical practice. The Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework was applied to evaluate reporting of individual and setting/staff-level intervention indicators. A systematic search and multi-step screening process identified 31 randomized controlled trials for psychosocial interventions for breast cancer-related pain. Average reporting of indicators for individual-level dimensions (Reach and Effectiveness) were 65.2% and 62.3%, respectively. Comparatively, indicators for setting/staff-level dimensions were reported at a lower average frequency (Implementation, 46.8%; Adoption, 15.2%; Maintenance, 7.7%). Low reporting of setting/staff-level dimensions suggests gaps in the sustained implementation of psychosocial interventions. Implementation science methods and frameworks could improve trial design and accelerate the translation of psychosocial interventions for breast cancer-related pain into clinical practice.

Keywords: Breast cancer; Cancer-related pain; Psychosocial intervention; RE-AIM.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Breast Neoplasms* / complications
  • Cancer Pain* / therapy
  • Cancer Survivors*
  • Female
  • Humans
  • Pain Management
  • Psychosocial Intervention